242 related articles for article (PubMed ID: 27637382)
1. Development of acetophenone ligands as potential neuroimaging agents for cholinesterases.
Jollymore-Hughes CT; Pottie IR; Martin E; Rosenberry TL; Darvesh S
Bioorg Med Chem; 2016 Nov; 24(21):5270-5279. PubMed ID: 27637382
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of acetophenone derivatives as dual binding acetylcholinesterase inhibitors.
Shen Y; Li B; Xu H; Zhang G
Pharmazie; 2013 May; 68(5):307-10. PubMed ID: 23802426
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
5. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities.
Luo W; Chen Y; Wang T; Hong C; Chang LP; Chang CC; Yang YC; Xie SQ; Wang CJ
Bioorg Med Chem; 2016 Feb; 24(4):672-80. PubMed ID: 26752094
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, crystal structure determination, biological screening and docking studies of N
Sultana N; Sarfraz M; Tanoli ST; Akram MS; Sadiq A; Rashid U; Tariq MI
Bioorg Chem; 2017 Jun; 72():256-267. PubMed ID: 28495556
[TBL] [Abstract][Full Text] [Related]
14. Molecular perception of interactions between bis(7)tacrine and cystamine-tacrine dimer with cholinesterases as the promising proposed agents for the treatment of Alzheimer's disease.
Eslami M; Hashemianzadeh SM; Bagherzadeh K; Seyed Sajadi SA
J Biomol Struct Dyn; 2016; 34(4):855-69. PubMed ID: 26043757
[TBL] [Abstract][Full Text] [Related]
15. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.
Knez D; Sova M; Košak U; Gobec S
Future Med Chem; 2017 May; 9(8):811-832. PubMed ID: 28504893
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
[TBL] [Abstract][Full Text] [Related]
17. Thioesters for the in vitro evaluation of agents to image brain cholinesterases.
Macdonald IR; Jollymore CT; Reid GA; Pottie IR; Martin E; Darvesh S
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):447-55. PubMed ID: 22233541
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticholinesterase activities of novel 1,3,4-thiadiazole based compounds.
Skrzypek A; Matysiak J; Karpińska MM; Niewiadomy A
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):816-23. PubMed ID: 22630076
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Qiang X; Li Y; Xu R; Cao Z; Song Q; Wang T; Zhang X; Liu H; Tan Z; Deng Y
Eur J Med Chem; 2017 Jul; 135():307-323. PubMed ID: 28458136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
